Hugo Geerts is Head Neuroscience Quantitative Systems Pharmacology (QSP) at Certara. His studies included a physics degree, a Biophysics PhD, a Bachelor Degree in Medicine, a Master in Pharmaceutical Sciences, and a Pharma Executive MBA. He worked for 17 years with Dr. Paul Janssen, the greatest drug hunter in history at the Janssen Research Foundation heading the Alzheimer Discovery research. He identified galantamine (Razadyne-Reminyl) for inlicensing and supported its successful clinical development in Alzheimer’s disease. In 2002, he co-founded In Silico Biosciences to provide mechanistic disease modeling services in CNS R&D (notably schizophrenia, Alzheimer’s and Parkinson’s disease. He joined Certara-SimCyp in 2020 to build out a comprehensive neuroscience QSP platform by combining advanced Physiology-Based PharmacoKinetic modeling with mechanism-based disease modeling. His passion is to get better drugs faster to the right patients by using translational computer modeling & simulation.